contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
      id
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    pageUrl
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


scanfil-guidance-indicates-gradual-improvement-in-2025-nordea

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Scanfil is an international electronics contract manufacturer specializing in industrial and B2B customers. Its service offering includes manufacturing of end-products and components such as PCBs. Manufacturing services are the core of the company supported by design, supply chain, and modernization services. It operates globally in Europe, the Americas, and Asia. Customers are mainly companies operating in process automation, energy efficiency, green transition, and medical segments.

Scanfil rapporterade ett ganska neutralt resultat för första kvartalet. Omsättningen minskade på grund av svag efterfrågan och uppstart av nya projekt. Aktien är rimligt prissatt, men förväntad avkastning lockar inte. Antti Viljakainen kommenterade i en intervju med Pia Maljanen.                   Inderes              Scanfil Q1’25: Share price has reached neutral zone - Inderes    Time: 2025-05-09 12:38 Scanfil's Q1 report was rather neutral. Revenue decreased by 3% and the negative top-line development was mainly caused by sluggish demand, while the ramp-up of several new projects at various factories also limited sales.

Scanfil investerar i en ny produktionslinje för elektronik vid sin fabrik i Atlanta, USA.                   Inderes              Scanfil investerar i en production line för elektronik vid sin fabrik i...    Scanfil meddelade igår att bolaget investerar i en andra production line för elektronik vid sin anläggning i Atlanta i USA. Efterfrågan på elektroniktillverkning i USA har ökat under de senaste två åren och väntas fortsätta att växa. Utbyggnaden...

My Scanfil is about to release its Q1 results soon — what does the analyst have to say…?                   Inderes              Scanfil Q1'25 earnings preview: Ramp-up of project wins to burden figures in...    Scanfil has ramped up production of new projects won last year, probably in several factories, which is likely to have depressed the company's growth and profitability in the first part of the year. As a result, we expect Scanfil's Q1 numbers to...

This is now a comprehensive, high-quality, and easy-to-read analysis of Scanfil!                     Inderes              Scanfil Extensive Report: Topline-driven value creation - Inderes    We expect Scanfil's playbook to remain viable, even though uncertainty related to investment-driven demand is now very high. In our view, the risk-adjusted expected return of the stock across all components is still slightly higher than the required...

Inderes              Scanfil Q4’24: No room for surprises - Inderes    Time: 2025-02-26 09:54 Scanfil’s performance is showing signs of a turnaround. In Q4, Scanfil's revenue decreased by 4% to 212 MEUR from a good comparison level, which was slightly above our forecast.                             Senaste videon på Scanfil - om Q4’24

Enligt Inderes analys verkar Scanfil’s resultatutveckling ha vänt i en positiv riktning, och risknivån har sjunkit något, vilket stödjer värderingen. I analysen höjdes riktkursen till 9,40 euro från tidigare 8,70 euro, och rekommendationen förblev på Accumulate-nivå. Värderingsmultiplarna (2025e P/E 13x, EV/EBIT 10x) tyder på en rimlig prissättning, och de långsiktiga tillväxtutsikterna ses fortfarande som attraktiva. Inderes betonar dock att den förväntade avkastningen för investerare i hög grad beror på om resultatökningen förverkligas. Läs rapporten                    Inderes              Scanfil Q4'24: Expected return determined by earnings growth - Inderes    The overall picture of Scanfil's Q4 report released on Friday was, in our view, cautiously positive, with the company's performance showing signs of a turnaround.

Scanfil Q4-rapport motsvarade förväntningarna utan några stora överraskningar. Omsättningen minskade med 4 %, men den organiska nedgången saktade in. Förvärvet av SRX och effektivitetsåtgärder stödde resultatet, och justerad EBIT steg till 14 MEUR. Resultatet per aktie sjönk till 0,14 euro. Prognosen för 2025 indikerar tillväxt, och bolaget fortsätter att överväga potentiella förvärv. Scanfil har åtminstone varit pålitligt de senaste åren och växt stabilt. Här är analytikerns kommentarer                     Inderes              Scanfil Q4'24 flash comment: Forecasts roughly in the middle of the guidance...    Scanfil released its Q4 report this morning. The surprise element related to the Q4 figures was very small due to the narrowed guidance in December, and the development in late 2024 was practically in line with our expectations. Scanfil plans to...

Scanfil

Revenue was down 3% y/y in Q1, but Scanfil kept its full-year revenue guidance unchanged and expects a gradual q/q improvement in Q2-Q4 2025. The company has not seen any order cancellations...

Revenue was down 3% y/y in Q1, but Scanfil kept its full-year revenue guidance unchanged and expects a gradual q/q improvement in Q2-Q4 2025. The company has not seen any order cancellations due to the trade war or a possible downturn. We calculate that average revenue growth needs to be 13.2% y/y in Q2-Q4 in order for the revenue guidance midpoint of EUR 850m in 2025 to be reached. As overall uncertainty regarding 2025 has increased, our net sales estimate is 3% below the guidance midpoint. The role of an EMS company is to offer the required production flexibility for brand owners, which also means that changes in end demand can be rapid. Our fair value range remains at EUR 8.1-10.0, based on three equally-weighted valuation approaches (DCF, EV/EBITDA and P/E). Marketing material commissioned by Scanfil Oyj.